Investigational device · For research use only

Swiss MedTech · Optical Polarimetric Imaging

The Future of Intraoperative Tissue Imaging

PolaSight is developing PolaOne, an optical polarimetric imaging platform designed to support real-time tissue assessment within the intraoperative pathology workflow.

PolaOne benchtop polarimetric imaging scanner

Fig. 1 · PolaOne — Benchtop polarimetric imaging platform

Est. 2024

The Challenge

A Clinical Bottleneck That Hasn't Changed in 130 Years

01

During cancer surgery, the pathology team is asked to deliver immediate insight into tissue that has just been removed. Today, that insight depends on rapid frozen section - a technique that is slow, destructive, and limited in scope.

02

The result is prolonged decision-making, pressure on the pathology lab, and tissue specimens that are partially consumed before they reach modern molecular workflows.

03

PolaSight is working to support the intraoperative pathology team with a faster, non-destructive imaging tool that integrates into their existing workflow.

The Solution

PolaOne: Optical Polarimetry for the Pathology Lab

PolaOne is a compact benchtop scanner that images fresh tissue specimens immediately after resection. No freezing. No staining. No tissue destruction.

Built on years of academic research at the University of Bern, PolaOne combines optical polarimetric imaging with advanced computational methods to produce visual maps of tissue properties for pathologist review.

01

Fast

Designed for rapid scanning that fits the pace of intraoperative consultation.

02

Non-Destructive

Tissue is preserved intact for all downstream pathology and molecular workflows.

03

Computationally Enhanced

Polarimetric data is processed to generate intuitive visual maps for the pathologist.

04

Pathology Workflow-Integrated

Engineered to fit within the existing intraoperative pathology consultation process, not replace it.

Polarimetric tissue imaging output

Fig. 2 · Polarimetric tissue map · Representative output

Origin

A Swiss Deep-Tech Spin-Out

PolaSight is a spin-out from the ARTORG Center for Biomedical Engineering Research at the University of Bern, building on more than a decade of academic research in biomedical optics and computational imaging.

The company is headquartered in Lausanne, Switzerland.

Recognition

Backed by Swiss Innovation

University of BernVenture KickInselpital

Supported by leading European MedTech ecosystems

Team

A Team Built at the Intersection of Optics, AI, and MedTech

Roi Finish

Roi Finish

Co-Founder & CEO

17+ years in MedTech. Previously Johnson & Johnson and Dentsply Sirona.

Davide Scandella

Davide Scandella

Co-Founder & CTO

Optical systems engineering and polarimetry hardware. ARTORG Center, University of Bern.

Dr. Pablo Márquez Neila

Dr. Pablo Márquez Neila

Co-Founder & CSO

15+ years in computational imaging and machine learning. ARTORG Center, University of Bern.

Prof. Dr. Raphaël Sznitman

Prof. Dr. Raphaël Sznitman

Co-Founder & Scientific Advisor

Director, ARTORG Center, University of Bern. Previous founder of RetinAI (acquired).

Get in Touch

Interested in PolaSight?

We are developing PolaOne with a focus on clinical impact, scientific rigor, and regulatory discipline. If you are a pathologist, clinician, hospital partner, researcher, or aligned investor and would like to learn more, we'd be glad to hear from you.

Location

Lausanne, Switzerland